Glaxo filed a patent application [872/CAL/98] for Abacavir Hemisulfate Salt [corresponding to Orange Book listed US6294540] with the Kolkata Office. This application was opposed by the Indian Network for People living with HIV/ AIDS [INP+].
Post the filing of Opposition, Glaxo has withdrawn the mentioned application. The Kolkata Patent Office vide a letter dated 01/Oct/2007 has confirmed that the application has been withdrawn by Glaxo.
Opposition brief from INP+;
Kolkata Patent Office letter declaring withdrawal of application by Glaxo.
Glaxo's earlier withdrawals from Indian Patent office, here [Combivir and Trizivir].
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment